股票/基金 实时行情 股吧

简称:广济药业 代码:000952


会计年度:2009-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
输液20,784,518.4218,606,775.332,177,743.0910.48
原料系列产品163,872,467.05132,948,869.0430,923,598.0118.87

会计年度:2008-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
核黄素496,226,220.99277,493,764.80----
输液43,054,828.1336,771,202.07----
核黄素496,226,221.00277,493,764.80----
输液43,054,828.1336,771,202.07----

会计年度:2008-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
核黄素331,557,300.00167,924,500.00----
医药制造业371,593,000.00201,194,300.00----
输液20,979,500.0021,162,900.00----
核黄素331,557,300.00167,924,500.00163,632,800.0049.35
输液20,979,500.0021,162,900.00-183,400.00--
医药制造业371,593,000.00201,194,300.00----

会计年度:2007-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
核黄素727,774,172.22287,049,522.26----
输液40,274,460.1232,601,634.74----
合计768,048,632.34319,651,157.00----
合计768,048,632.30319,651,157.00----
核黄素727,774,172.20287,049,522.30440,724,650.0060.56
输液40,274,460.1232,601,634.747,672,825.3819.05
医药制造业794,903,350.92337,905,208.90----

会计年度:2007-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
核黄素229,703,726.30133,056,152.19----
输液24,649,068.5619,267,946.97----
其中:关联交易--------
合计254,352,794.86152,324,099.16----
合计254,352,794.86152,324,099.16----
核黄素229,703,726.30133,056,152.1996,647,574.1142.07
其中:关联交易--------
输液24,649,068.5619,267,946.975,381,121.5921.83
医药制造业262,239,212.05159,301,761.01----

    6/9 转到